Business
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel.
About this update from Amarantus Bioscience Holdings, Inc.
[{"type":"text","content":"\nREHOVOT, Israel, May 21, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders such as Alzheimer's disease, today announced the signing of a Distribution Agreement with Care G.B. Plus, Ltd. for exclusive distribution rights of Todos Medical Ltd.’s innovative and cost-effective TM-B2 blood tests for breast cancer screening in the State of Israel.\n “We recently have initiated commercialization of our breast cancer screen (TM-B1) in two European markets. Today, we are proud to announce the signing of an exclusive distribution agreement with Care G.B. Plus, Ltd. for the territory of the State of Israel,” said Dr. Herman Weiss, CEO of Todos Medical. “Since inception, Todos Medical has worked diligently to bring our breast cancer screening technology to commercialization to help patients and their physicians identify cancer earlier in the disease process using a simple blood test. Today, Todos Medical has taken another step in bringing our innovative products to the general public.” “When Todos Medical came to our attention, we knew immediately that we wanted to play a role in offering their proprietary cancer screenings for breast cancer to the Israeli public,” said Mr. Assaf Gold, CEO of Care G.B. Plus. “We look forward to working with Todos for many years to come.” Care G.B. Plus, Ltd. will be responsible for marketing and distribution costs and execution associated with commercializing the breast cancer tests in Israel. Todos Medical will be able to use the data gathered from these initiatives to support further development and commercialization in other jurisdictions. About Todos MedicalTodos Medical Ltd. (OTCQB: TOMDF), an Israeli company headquartered in Rehovot, is a cancer in-vitro-diagnostic (“IVD”) company engaged in the development of a series of blood tests for the early detection of a variety of cancers and has initiated the development of blood tests for neurodegenerative disorders, such as Alzheimer's disease, through Breakthrough Diagnostics, Inc. its joint venture with Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS). The company has developed two cancer screening tests based on TBIA (Tod...